Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Bone Therapeutics to enhance value of its severe osteoporosis program by transitioning to allogeneic development

Date
Thu, 05/19/2016 - 12:00
Year
2016
Filter Criteria
Press Releases
Link
https://us9.campaign-archive.com/?u=514b2fb84e2983c90f0acbd2a&id=7872d8ecf2
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions